Aurobindo Pharma to make COVAXX s potential COVID-19 vaccine for India, UNICEF | WSAU News/Talk 550 AM · 99 9 FM wsau.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wsau.com Daily Mail and Mail on Sunday newspapers.
Aurobindo Pharma has exclusive rights to develop and commercialize UB-612 in India and to UNICEF and non-exclusive rights in other select emerging markets .
Published: Dec 23, 2020
MALVERN, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) Ocugen, Inc., (NASDAQ: OCGN), a leading biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies, today announced the appointment of a vaccine scientific advisory board comprised of leading academic and industry experts in the vaccine field to evaluate the clinical and regulatory path to approval in the US market of Bharat Biotech’s COVAXIN™, a whole-virion inactivated COVID-19 vaccine candidate to be co-developed by Ocugen and Bharat Biotech for the US market.
Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen remarked, “We are thrilled to welcome this group of esteemed thought leaders to the Ocugen team to assist in our co-development with Bharat Biotech of COVAXIN™. This unique yet traditional vaccine candidate is different from other options currently available in the US market with potentially broader coverage against multip
Aurobindo Pharma set to make COVAXX s potential COVID-19 vaccine for India, UNICEF
SECTIONS
Last Updated: Dec 24, 2020, 10:07 AM IST
Share
Synopsis
COVAXX, a unit of privately-owned United Biomedical Inc, plans to pursue mid- and late-stage trials for the vaccine candidate from early 2021 in Asia, Latin America and the United States.
Reuters
BENGALURU: Aurobindo Pharma Ltd said on Thursday it would make and sell U.S.-based COVAXX s COVID-19 vaccine candidate for supply in India and to the United Nations Children s Fund (UNICEF) under a licensing deal.
The Indian drugmaker also has non-exclusive rights to sell the shot which is currently undergoing an early-stage trial in certain other emerging markets, the Hyderabad-based company said in an exchange filing.
Aurobindo Pharma Enters Licensing Pact With US Biotech COVAXX For Manufacture, Sale Of COVID-19 Vaccine moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.